ArticleCardiovascular and interventional radiology2025
Qualitative Assessment of the Patient-Reported Outcome Measure for Vascular Malformation (PROVAM) Questionnaire in Patients with Low-Flow Vascular Malformations: A Prospective Cohort Study.
Article in Cardiovascular and interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study analyzed factors influencing pain, bothersome symptoms, and unmet concerns in low-flow vascular malformations (LFVM) using qualitative insights from Patient-Reported Outcome Measure for Vascular Malformation (PROVAM) questionnaires. MATERIALS AND
methodsBetween July 2019 and February 2022, 327 patients with LFVM at a vascular anomalies clinic completed 439 PROVAM questionnaires. The 30-item instrument includes four free-text questions on factors that affect pain, bothersome symptoms, and issues not captured elsewhere. All responses were analyzed by a directed content-analysis approach within three domains: physical (PD), emotional/social well-being (ESD), and functional (FD) regarding LFVMs in the head and neck (H&N), upper extremity (UE), lower extremity (LE), and trunk.
resultsOf 439 questionnaires, 319 (72.7%) reported factors affecting pain. Increased activity (159/319, 49.8%) and physical pressure on the LFVM (110/319, 34.5%) worsened pain. Out of 323 responses (73.6%), the most bothersome symptoms related to the PD (261/323, 80.8%), followed by ESD (52/323, 16.1%) and FD (H&N: 15/323, 4.6%; UE, LE, trunk: 46/323, 14.2%). The most common themes were pain or discomfort (192/323, 59.4%) in the PD, appearance (28/323, 8.7%) in the ESD, effect on eating/drinking (9/323, 2.8%) in the FD (H&N), and effect on walking, standing, sitting, or lying down (21/323, 6.5%) in the FD (UE, LE, trunk).
conclusionQualitative analysis of PROVAM responses revealed diverse factors affecting the quality of life for LFVM patients, including symptom triggers, most bothersome symptoms, and issues not covered in the quantitative survey. These insights highlight the importance of the qualitative survey in understanding this heterogeneous disease.
Indexed as
Identifiers
41094085What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.